INSTI® self-testing of HIV in Canada produces effects in 1 minute and has an accuracy of more than 99%
VANCOUVER, British Columbia, 3 November 2020 (GLOBE NEWSWIRE) – For the first time, Canadians will need to use HIV self-testing kits at home. BioLytical Laboratories, a world leader in immediate infectious disease testing, today announced that it has been authorized through Health Canada to produce and sell its one-minute INSTI® HIV self-tests in Canada.
Compared to home pregnancy control, HIV inSTI self-control® allows Americans to stumble and control HIV from the comfort of their own home, with easy-to-understand instructions in three steps. Examiners collect a drop of blood using an undeniable scoring method. and get accurate effects in over 99% in just 1 minute. INSTI HIV self-testing® is a component of the world’s leading 1-minute biolytic control line for infectious diseases such as HIV, hepatitis C, syphilis and now COVID-19.
Contrary to popular belief, HIV infections are still present in Canada. It is estimated that 14% of people living with HIV nationwide do not know their status. The advent of HIV self-testing provides new opportunities to succeed in other undiagnosed people, which can lead to better physical fitness outcomes and fewer new HIV transmissions.
“Ending the HIV epidemic begins with testing. By providing cutting-edge features like our INSTI® HIV autotest in 1 minute, we can help others who don’t know the prestige of HIV know the facts and make fitness decisions much faster,” says BioLytical CEO Robert Mackie: “In addition, bioLytical has gained approval in Europe and lately the FDA is being tested for our COVID-19 antibody test , which uses the same one-minute INS®TI self-test technology. “
Approval for HIV self-test inSTI® comes a year after the launch of a state-of-the-art box exam at 3 sites across Canada that showed that other people without medical education can simply take the one-minute self-test and as it should The study was jointly funded by THE CHR CENTER for REACH 3. 0 and the Canadian AIDS Research Foundation (CANFAR) and led by Dr. Sean B. Rourke of the MAP Center Urban Health Solutions at St. Michael’s.
The test provided knowledge to Health Canada’s application for a bioLytical license, indicating that users discovered that INSTI® HIV self-testing was accurate and easy to use. In fact, more than 95% of test participants indicated that they would use INSTI again and introduced them to family, friends, and sexual partners.
Dr Rourke said: “We are very happy to introduce HIV self-testing in Canada to succeed in other undiagnosed people; it’s been needed for a long time and without this option we won’t be able to finish it. Hiv epidemic in Canada. REACH, now approved, works intensively with leading HIV organizations and other fitness agencies to develop, implement and extend a national teleattitude (online) platform with peer navigators to access and self-HIV. evidence as well as liaison carefully. “
The check can be purchased this week at INSTI. com. For more information and to request updates, visit insti. com/self-check-canada.
About BioLytical Laboratories Inc.
bioLytical Laboratories Inc. es a private Canadian company aimed at the research, progression and commercialization of immediate in vitro medical diagnoses. Using its patented INSTI® generation platform, the bioLytical product line includes the INSTI® HIV-1/ HIV-2 antibody test, the INSTI test® Multiplex HIV/Syphilis and INSTI® HIV Self Test, as well as the new INSTI® tests for COVID-19 and HCV. With global regulatory approvals, in addition to U. S. FDA approval, the U. S. FDA has not been approved. USA, Health Canada approval, WHO prequalification and CE mark, INSTI has significant effects on patients, fitness professionals, taxpayers and public fitness organizations, while contributing to global fitness strategies. For more information, visit www. insti. com.